| The targeted cancer pill – Gleevec - has been approved for the treatment of gastrointestinal stromal tumors, pediatric CML, as well as five additional rare cancers.
While it has been reported to have... | |
| |
| According to a new study led by Duke University Medical Center researchers, test for four blood proteins may provide a less-invasive follow-up for patients who have suspicious lesions on chest... | |
| |
| We already know that smokers have a higher risk of developing lung cancer.
However, smokers and non-smokers alike may be able to substantially reduce the risk of developing lung cancer by simply... | |
| |
| I’ve blogged on and on above the beneficial effects of a fruits-and-vegetable-rich diet against cancer.
Though the effects are not immediate, in the long run, such diet has a role on cancer... | |
| |
| According to University of Florida surgeons, in about 20 percent of women with breast cancer who plan to undergo a lumpectomy, breast magnetic resonance imaging reveals important diagnostic... | |
| |
| The powerful anti-cancer drug imatinib (Gleevec™) has been re-engineered by researchers at Rice University and the University of Texas M. D. Anderson Cancer Center.
Developed by Novartis... | |
| |
| At around 5 am today, we got back from our long weekend.
I endured a stiff neck from a 12-hour bus ride home.
Stiff neck and all, I am back to blog, so please come back soon.
Share This | |
| |
| We know how green tea has become popular for its anti-cancer ingredients.
Now, Moffitt Cancer Center is looking for volunteers/participants in a green tea study:
Moffitt Cancer Center is looking to... | |
| |
| While cryoablation is working wonders in kidney cancer patients will unoperable tumors, the procedure has been found to offer durable pain relief of cancer that has spread to the bone – according to... | |
| |
| This is a difficult week for me. Not only I am trying to wrap up on my blogging commitments before we go out of town on Friday, the weather isn’t cooperating.
The other super typhoon already left but... | |
| |
| |
| | |
|
|
|
|
